Efficacy of BNG-1 to Treat Acute Ischemic Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 129 participants.

Also called NCT01675115

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 129 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01675115
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01675115. Randomized; quadruple masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2014-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of BNG-1 to Treat Acute Ischemic Stroke
Acronym
BNG-1
Intervention (Drug)
BNG-1
Intervention (Drug)
Aspirin
Lead sponsor
Chang Gung Memorial Hospital (class: other)

Record details

Record id
cardio:ct-nct01675115
Content hash
4884ec126f1781d1e493fa969fdeb18afe08d27375b16a6b4225c45531c4d29e